Abstract
Treatment, Prognostic Markers, and Survival in Thymic Neuroendocrine Tumors, with Special Reference to Temozolomide-Based Chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.3390/cancers16142502
Journal: Cancers | Publication Date: Jul 10, 2024 |
License type: cc-by |
Treatment, Prognostic Markers, and Survival in Thymic Neuroendocrine Tumors, with Special Reference to Temozolomide-Based Chemotherapy
Join us for a 30 min session where you can share your feedback and ask us any queries you have